Loading viewer...
investor_presentation
Format: PDF investor_presentation
1COMPANY OVERVIEW Dinesh V. Patel, PhD | President & CEO January 2022
Dinesh V. Patel, PhD | President & CEO
January 2022Forward- looking Statements
2This presentation and the accompanying oral presentation contain forward -looking statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation, including
statements regarding our future results of operations and financial position, business strategy, product candidates, capital resources, potential markets
for our product candidates, enrollment in our clinical trials, any potential impact on our business related to COVID-19, our pot ential receipt of milestone
payments and royalties under our Collaboration Agreement with Janssen Biotech, Inc., are forward-looking statements. In some ca ses, you can identify
forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potentially”
“predict,” “should,” “will” or the negative of these terms or other similar expressions.
The forward -looking statements made in this presentation involve known and unknown risks, uncertainties and other important fact ors that may cause
our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by
the forward -looking statements. These forward -looking statements are subject to risks and uncertainties, including those discussed in Protagonist’s
filings with the Securities and Exchange Commission, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition
and Results of Operations” sections of most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings and in the documents
incorporated by reference therein. Because forward -looking statements are inherently subject to risks and uncertainties, some of which cannot be
predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future
events. The events and circumstances reflected in our forward -looking statements may not be achieved or occur and actual results could differ materially
from those projected in the forward -looking statements. Except as required by applicable law, we do not plan to publicly update or revise any forward -
looking statements contained herein, whether as a result of any new information, future events, changed circumstances or othe rwise.
This presentation concerns products that are under clinical investigation and which have not yet been approved for marketing by the U.S. Food and Drug
Administration. They are currently limited by Federal law to investigational use, and no representation is made as to their s afety or effectiveness for the
purposes for which they are being investigated. The trademarks included herein are the property of the owners thereof and are used for reference
Preview truncated — download the full document for the complete content.
investor_presentation
57 Pages
investor_presentation
59 Pages
Eldorado Gold
Vishnusurya Projects And Infra FY24 Investor Presentation June 2024
investor_presentationinvestor_presentation
31 Pages
Vishnusurya Projects And Infra Limited
Adani Green Energy Khavda Renewable Project 2024
investor_presentationinvestor_presentation
30 Pages
Adani Green Energy Limited